Table 4 Reclassification of biopsies according to newly proposed criteria.
From: Evaluation of the lower histologic threshold for gastric graft versus host disease
Negative for graft-versus-host disease (n = 17) | Indeterminate for graft-versus-host disease (n = 30) | Positive for graft-versus-host disease (n = 18) | P value | |
|---|---|---|---|---|
Graft-versus-host disease treatment | 8/16 (50%) | 21 (70%) | 16/17 (94%) | 0.02 |
Response to treatment | 8 (100%) | 18/20 (90%) | 14/16 (88%) | 0.59 |
Graft-versus-host disease in nongastric biopsies | 7 (41%) | 18 (60%) | 14 (78%) | 0.09 |
Extraintestinal graft-versus-host disease | 7 (41%) | 11 (37%) | 12 (67%) | 0.11 |
